Stockscreener 앱 받기
1.63
3.16%
0.05
시간 외 거래:
1.62
-0.010
-0.61%
전일 마감가:
$1.58
열려 있는:
$1.6
하루 거래량:
417.93K
Relative Volume:
1.51
시가총액:
$58.77M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-1.0455
EPS:
-1.559
순현금흐름:
-
1주 성능:
+35.83%
1개월 성능:
+45.54%
6개월 성능:
-32.08%
1년 성능:
-74.96%
1일 변동 폭
$1.58
$1.80
1주일 범위
$1.20
$1.80
52주 변동 폭
$0.873
$7.89
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
GUTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.63 | 58.77M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Geode Capital Management LLC Purchases 11,603 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. to Present Preclinical Data on Rejuva Gene Therapy Platform at ASGCT 2025 Annual Meeting - Nasdaq
Fractyl Health to Present Compelling Preclinical Data from - GlobeNewswire
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting - Yahoo Finance
Discover Fractyl Health And 2 More Promising Penny Stocks - Yahoo Finance
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Analysts at Canaccord Genuity Group - Defense World
Fractyl Health initiated with a Buy at Canaccord - TipRanks
Raymond James Financial Inc. Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Sei Investments Co. Acquires Shares of 27,778 Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Norges Bank Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Critical Analysis: Glaukos (NYSE:GKOS) & Fractyl Health (NASDAQ:GUTS) - Defense World
NeuroMetrix (NASDAQ:NURO) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Survey - Defense World
HighTower Advisors LLC Acquires 10,921 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025 - Insider Monkey
10 Micro-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey
Fractyl Health Reports Positive Early Data Showing Revita® - GlobeNewswire
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation - The Manila Times
Fractyl Health, Inc. (NASDAQ:GUTS) Shares Acquired by Bank of New York Mellon Corp - Defense World
16,414 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Purchased by Intech Investment Management LLC - The AM Reporter
Fractyl Health director Barnes acquires $40,210 in common stock - Investing.com India
Fractyl Health director Ajay Royan purchases $22,979 in common stock By Investing.com - Investing.com Australia
Fractyl Health director Ajay Royan purchases $22,979 in common stock - Investing.com India
FRACTYL HEALTH Executives Increase Their Stakes - TradingView
Fractyl Health director Barnes acquires $40,210 in common stock By Investing.com - Investing.com UK
FRACTYL HEALTH Director Bradley William Acquires 16,129 Shares - TradingView
Fractyl Health sets June 11 for 2025 stockholder meeting - Investing.com
Fractyl Health sets June 11 for 2025 stockholder meeting By Investing.com - Investing.com South Africa
Rhumbline Advisers Boosts Stock Holdings in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks - Yahoo Finance
Fractyl Health Reports 2024 Financial Results and Strategic Progress - MSN
Earnings call transcript: Fractyl Health’s Q4 2024 results miss expectations, stock drops - Investing.com India
FRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly Earnings - Nasdaq
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - TradingView
Fractyl Health Highlights Urgent Demand for Weight Maintenance Solutions Post-GLP-1 Therapy in Upcoming REMAIN-1 Study Amid Strategic Focus on Metabolic Health - Nasdaq
Fractyl's Weight Maintenance Study Hits 189 Patients: Can It Solve the GLP-1 Rebound Problem? - StockTitan
Earnings Scheduled For March 3, 2025 - Benzinga
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 - The Manila Times
Fractyl Health to Report Fourth Quarter and Full Year 2024 - GlobeNewswire
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide ... - The Bakersfield Californian
Can This Metabolic Disease Pioneer Deliver Strong Q4 Results? Fractyl Health Reports March 3 - StockTitan
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Drop in Short Interest - MarketBeat
Stratos Wealth Partners LTD. Sells 21,148 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS) - Yahoo Finance
Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - PharmaVoice
Insider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of Stock - MarketBeat
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):